Developed in Western Australia, the Soluna apple is renowned for its deep burgundy skin, outstanding crunch, and balanced, ...

Earlier this year, Peso Pluma — a 24-year-old who grew up in between Guadalajara, Jalisco, and San Antonio — became the first regional Mexican... Regional Goes Global, Part 1: Finding Peso Pluma's ...

Saks Global is laying off about 16% of its corporate staff as it seeks to emerge from bankruptcy protection later this year, according to a person familiar with the situation. About 640 jobs are being ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

S15 - E19 Reunion Part 1 The reunion kicks off with some of the ladies seeking resolution while others remain doubtful following an emotionally charged season. A red-carpet sighting sparks questions ...

March 19 (Reuters) - Realty Income (O.N), opens new tab said on Thursday it will get $1 billion from asset manager ‌Apollo Global Management (APO.N), opens new tab and affiliates for a 49% interest in ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Andy Brinkmeyer shares how engineering ...

Global EV sales hit 1.1 million units in February 2026, according to new data from Benchmark Mineral Intelligence. But the global market is now splitting sharply by region. While Europe’s EV sales are ...

Tolerability profile supported by dosimetry and low-grade non-hematologic events. Lesion dosimetry indicates no difference in absorbed dose profile across cohorts. No adverse drug-drug interactions ...

Good morning, everybody. My name is Kyahn Williamson, SVP of Investor Relations and Corporate Communications at Telix. And we're very pleased to welcome you today to our investor call and webcast to ...

MELBOURNE, Australia and INDIANAPOLIS, March 10, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that Part 1 of the ProstACT Global Phase 3 study, ...